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Background: Adenoid cystic carcinoma is a malignant epithelial tumor derived from salivary glands and tends to
invade the surrounding structures including nervous system. We present a case of adenoid cystic carcinoma with
intracranial extension and propose a novel molecular mechanism of adenoid cystic carcinoma metastasis.
Case presentation: A 29-year-old Japanese male presented with left trigeminal nerve disturbance. Neuroimaging
revealed a tumor located at the right middle cranial and infratemporal fossa. The tumor was removed via a
subtemporal extradural and infratemporal fossa approach and histologically diagnosed as adenoid cystic carcinoma.
Radiological and operative findings confirmed a perineural spread of the tumor along the mandibular nerve.
Immunohistochemical analyses of molecular consequences in this case were performed for better understanding
of the biological processes associated with adenoid cystic carcinoma metastasis. First, the neoplastic cells were not
immunoreactive for E-cadherin, an epithelial marker, but for vimentin, a mesenchymal marker, suggesting changes
in cell phenotype from epithelial to mesenchymal states. Correspondingly, immunoreactivity of transcriptional factors,
such as Slug, Twist, matrix metalloproteinase-2 and -9, which are involved in epithelial–mesenchymal transition, were
observed. Second, elevated expression of EphA2 receptor, not ephrin-A1, was notable in the neoplastic cells, suggesting
morphological changes reminiscent of epithelial–mesenchymal transition and ligand-independent promotion of tumor
cell migration and invasion.
Conclusions: We report a case of adenoid cystic carcinoma with perineural spread and provide the first published
evidence that EphA2 expression without ephrin-A1 and epithelial–mesenchymal transition might play important roles
in adenoid cystic carcinoma progression.
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Adenoid cystic carcinoma (ACC), a malignant epithelial
neoplasm, is a rare tumor entity and comprises about
1% of all malignant tumor of the oral and maxillofacial
region [1]. It is a slowly growing but highly invasive can-
cer with high recurrence rate. Intracranial ACC even is
more rare and has been reported as 4 – 22% of ACC [2].
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unless otherwise stated.either by direct invasion, hematogenous spread, or peri-
neural infiltration [1]. The most common route is via
contiguous perineural invasion [2]. Many authors de-
scribe worse prognosis for ACC of the minor salivary
glands, due to early local infiltration and invasion of sur-
rounding tissue and bone [1]. However, molecular path-
ology of the high invasive and metastatic potential of
ACC is not well understood. Better understanding of the
biological processes associated with ACC invasion and
metastasis could provide a new approach to improve
prognosis of the patients with ACC.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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conversion of cells with an epithelial phenotype into cells
with a highly motile fibroblastoid or mesenchymal pheno-
type [3]. Diverse signaling pathways can regulate an EMT
program [4]. The process of EMT is characterized by loss
of intercellular adhesion and polarity, cytoskeletal reorga-
nization that enhances cell motility, and degradation of
the basement membrane. EMT is a critical mechanism in
embryonic development, chronic inflammation and fibro-
sis, and is considered to play a key role in tumor progres-
sion and metastasis [4]. Therefore, it is speculated that
EMTcould be involved in ACC invasion and metastasis.
The Eph receptors represent the largest family of recep-
tor protein tyrosine kinases and interact with their ligands,
ephrins [5]. Eph-ephrin signaling is fundamentally in-
volved in developmental processes or in the remodeling of
blood vessels and mainly affects the cell shape and motility
by regulating cytoskeletal organization and cell adhesion,
and also influences cell proliferation and cell-fate deter-
mination [6]. So far, the genes for Eph receptors and
ephrins have been recognized to be differentially expressed
in various human tumors [5]. Previous bodies of evidence
have implicated Eph involvement in the altered tumor
behavior such as increased invasiveness or increased
metastatic potential, and consequently with poor pa-
tient outcome [5]. Therefore, it is supposed that Eph
signaling could play some roles in tumor progression of
ACC as one of their possible consequences.
In this article, we report a case of ACC arising in the
infratemporal fossa and extending into the middle cranial
base through the foramen ovale along the mandibular
nerve. With this case, molecular pathology of ACC inva-
sion and metastasis is also discussed, focusing on EMT
program and EphA2 signaling as a possible mechanism.
Materials and methods
Clinical sample
The protocol is in compliance with the Helsinki Declar-
ation and was ethically approved by the institutional re-
view board at Wakayama Medical University (Permit
number: 61). Fresh tumor tissue and written informed
consent were obtained from the patient
Antibodies
Antibodies were purchased as follows: rabbit monoclonal
to E-cadherin (3195, Cell Signalling, Boston, MA, USA; di-
lution, 1:400) and Slug (9585, Cell Signalling; dilution,
1:100), mouse monoclonal to Vimentin (m0725, DakoCy-
tomation, Kyoto, Japan: dilution, 1:2500), Twist (ab50887,
Abcam, Cambridge, UK; dilution, 1:250) and matrix
metalloproteinase-2 (MMP-2) (MS804, ThermoFisher
Scientific, Cheshire, UK; dilution, 1:100) and rabbit
polyclonal to EphA2 (sc-924, Santa Cruz Biotechnology,
CA USA; dilution, 1:50), ephrinA1 (sc-20719, Santa CruzBiotechnology; dilution, 1:50), MMP-9 (RB9234, Thermo-
Fisher Scientific; dilution, 1:500).
Immunohistochemistry
Immunohistochemistry was carried out using the VEC-
TASTAIN® ABC kit (Vector Laboratories, Burlingame,
CA, USA). Briefly, paraffin sections were deparaffinized in
xylene and rehydrated through a graded series of ethanol
dilutions. Endogenous peroxidase activity was blocked
by incubation in 0.3% hydrogen peroxidase for 30 mi-
nutes. After pretreatments performed according to manu-
facturer’s instructions, sections were incubated at room
temperature for 1 h with primary antibody, and visualized
with diaminobenzidine. Diaminobenzidine was used as the
final chromogen. Immunostained cells were examined
under a microscope (Keyence Biozero, Osaka, Japan).
Reverse transcription polymerase chain reaction (RT-PCR)
After washing twice with ice-cold PBS, 1 mL of IsoGene
(Nippongene, Toyama, Japan) reagent was added to an
excised tissue. Sample was stored at -80°C. Total ribo-
nucleic acid (RNA) was isolated following the IsoGene
protocol as described by the manufacturer. Commercially
available total RNA of human normal salivary gland
(BioChain Institute, Inc., SF, USA) was used as a con-
trol. EphA2 messenger RNA (mRNA) expression was an-
alyzed by RT-PCR with TaKaRa RNA PCR Kit (AMV)
Ver.3.0 (TakaraBio, Shiga, Japan) also as instructed.
RT-PCR for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) served as an internal control. Primer sequences
for human EphA2 (369 bp) and GAPDH (408 bp) were
5'- GCA GGA GAG TTT GGG GAG GTG T-3’ & 5'-
GGT TGC TGT TGA CGA GGA TGT T-3’ and 5'-CCC
ATC ACC ATC TTC CAG GAG-3’ & 5'-AGG GAT GAT
GTT CTG GAG AGC C- 3', respectively.
Case presentation
A previously healthy 29-year-old Japanese man presented
with numbness of the left face that progressed over the
next month, followed by chewing difficulty. A physical
examination revealed left fifth cranial nerve palsy. Com-
puted tomography scanning of the head demonstrated a
mass in the left middle cranial fossa and widening of the
foramen ovale (Figure 1). Magnetic resonance imaging re-
vealed the mass involving the left infra-temporal and mid-
dle cranial fossa (Figure 1). The mass was removed via a
subtemporal epidural and infra-temporal fossa approach;
after total removal of the mass in the middle fossa, the
dilated foramen ovale was visible, and an infratemporal
fossa mass was removed as much as possible (Figure 1).
Intraoperative findings supposed the infratemporal fossa
tumor extending intracranially along the mandibular
nerve. Histological examination revealed a moderately
cellular tumor composed of compact epithelial cells
Figure 1 Pre-, Intra-, and Post-operative findings of the present
case. A and B, Gadolinium-enhanced T1-weighted magnetic resonance
images revealing a mass in the infra-temporal and middle cranial fossa
(circle). C, Three-dimensional bone image computed tomography scan
demonstrating widening of the foramen ovale (circle). D, Intra-operative
finding showing the tumor and enlarged foramen ovale. E and F,
Postoperative gadolinium-enhanced T1-weighted magnetic resonance
images manifesting removal of the tumor (circle).
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(Figure 2). In differentiated tubules, myxoid and colloid
materials were contained. Degenerative neural bundles
were also seen, suggesting a perineural invasion. The
tumor cells were immunoreactive for cytokeratin AE1/
AE3. Molecular immunology Borstel-1 (MIB-1) staining
index in the solid form were around 10%, suggesting
higher grade than typical ACC. This pathological ana-
lysis indicated ACC of the minor salivary glands. The
patient underwent fractionated irradiation of the lesion.Molecular pathology
For better understanding of the biological factors associ-
ated with ACC metastasis, we performed immunohisto-
chemical analyses. First, we hypothesized that EMT might
be involved in the metastatic process of ACC, because
accumulating evidence suggest that epithelial tumor cells
can switch from a sessile, epithelial phenotype to a motile,
mesenchymal phenotype referred to as EMT, resulting in
tumor migration and metastasis [7]. The loss of typical
epithelial cell markers, such as E-cadherin, and the gain of
mesenchymal markers, such as vimentin, are hallmarks of
EMT [7]. Indeed, the neoplastic cells were immunoreac-
tive for E-cadherin, but not for vimentin in the present
case (Figure 3). Correspondingly, immunoreactivity of
transcriptional factors, such as Slug, Twist, MMP-2 and
MMP-9, which have been reported to be involved in
EMT, were observed (Figure 4). These findings suggest
that EMT might be induced in this case, although it
remains unclear which factor could induce this event.
Second, we suspected the involvement of aberrant ex-
pression of Eph receptor tyrosine kinases and their
ephrin ligands in the ACC metastasis, because Eph
receptors and ephrins have been shown to affect the
migration and invasion of cancer cells in culture as well
as tumor invasiveness and metastasis in vivo [5]. In the
present case, higher staining intensity for EphA2 recep-
tor, not for ephrin-A1, was notable in the neoplastic
cells (Figure 5). For reference, the EphA2 were identified
in ACC frozen tissues by RT-PCR, with higher mRNA
expression in ACC tissues than normal salivary glands
(Figure 5). From these findings, it was revealed that ele-
vated expression of EphA2 without ephrin-A1 might
occur in this case. Taken together, our immunohisto-
chemical analyses suggest that EphA2 signaling and
EMT program might be associated with ACC metastatic
process.
Discussion
We report a case of ACC arising from the minor salivary
gland and extending into the middle cranial fossa along
the mandibular nerve. In this case, it is considered that
ACC perineurally spread from extracranial to intracranial
space, in that ACC is characterized by extensive migration
and invasion along basement membrane-rich tissues,
such as perineural and vascular sheaths. ACC is the
well-known malignancy with a propensity for perineural
invasion, whereas the molecular mechanism behind
metastatic process remains unclear. Thus we performed
an immunohistochemical analysis demonstrating that
overexpression of EphA2 and induction of EMT occurred
in the tumor cells of this case. These findings suggest
that EphA2 signaling and EMT program might be
potentially involved in invasive and metastatic potential
of ACC.
Figure 2 Histopathological findings of the present case. A, Photomicrographs of the tumor specimen showing a moderately cellular tumor
composed of compact epithelial cells showing tubular pattern. Hematoxylin & Eosin. Original magnification × 200. B, Alcian-blue stain revealing
myxoid or colloid materials in the tubules. C, Molecular immunology Borstel-1 (MIB-1) staining index indicating around 10%. D, Immunohistochemistry
for neurofibrillary protein demonstrating neural bundles in the tumor.
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primary tumors is an absolute requirement for metasta-
sis [7]. A process that causes a functional phenotypic
transition of polarized epithelial state into migratory
mesenchymal state, referred to as EMT, should be
necessary. Our observation of decreased expression of
E-cadherin, an epithelial cell marker, in the immuno-
histochemistry of the present case revealed a loss in
epithelial characteristics of cancer cells. Transcriptional
factors, Slug and Twist, expression and nuclear trans-
location were observed, leading to potential repression
of E-cadherin and induction of EMT. Then, expression
of vimentin and MMPs represents cytoskeletal reor-
ganization that enhances cell motility and proteinase
secretion for degradation of the basement membrane,
respectively, frequently considered to acquire mesen-
chymal features. Recently, Ishii et al. revealed that EMTFigure 3 Epithelial-mesenchymal transition in the present case. Immu
(A), an epithelial marker, is almost negative in the tumor cell, while vimentin (Bis involved in the ACC metastasis by means of a DNA
microarray analysis using their ACC cell lines [8]. Taken
together, it appears that the EMT is a key developmen-
tal program that is often activated during ACC invasion
and metastasis.
The Eph receptors and ephrins are divided into two
subclasses, A and B, based on their homologies, struc-
tures, and binding affinities [5]. Fourteen Eph receptors
and eight ephrin ligands have been identified so far in
mammals [5]. In the previous reports, one family mem-
ber, EphA2, is strongly overexpressed in many types of
tumor, such as glioblastomas, ovarian cancers and pros-
tate adenocarcinomas, and the increased expression of
EphA2 correlates with enhanced metastatic potential
and poor prognosis [9]. Here, we determined high ex-
pression of EphA2 in clinical specimens of ACC in both
protein and mRNA levels. Noticeably, ephrinA1 wasnohistochemistry for E-cadherin (A) and vimentin (B). Note that E-cadherin
), a mesenchymal marker, is positive.
Figure 4 Epithelial-mesenchymal transition in the present case. Immunohistochemistry for transcriptional factors, Slug (A) and Twist (B).
Nuclear staining for Slug and Twist was observed in the neoplastic cells. Immunohistochemistry for mesenchymal markers, matrix metalloproteinase-2
(C) and -9 (D). Both matrix metalloproteinase-2 (C) and -9 (D) are expressed in the tumor cells.
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overexpressed in our case, as the expression pattern of
ephrinA1 in some tumors was documented different
from EphA2 [9]. On the other hand, there is a recent
study showing that not only EphA2 but also ephrinA1
was highly expressed in adenoid cystic carcinoma and
correlated with tumor invasion [10]. In this study, the
authors also described that EphA2 was present in
a non-tyrosine-phosphorylated state despite of highFigure 5 EphA2 and ephrinA1 expression in the present case.
Immunohistochemistry for EphA2 (A) and ephrinA1 (B). Note that
EphA2 (A) staining is positive in the tumor cell, while ephrinA1 (B) is
negative. Original magnification × 200. (C), EphA2 was identified in
the frozen tissue by reverse transcription-PCR, with higher mRNA
expression in the tumor than normal salivary gland.expression of ephrin-A1. In terms of this point, Miao and
his colleagues reported on the diametrically opposite roles
of EphA2 in regulating cell migration and invasion; while
activation of EphA2 with ephrin-A1 inhibited migration of
cancer cells, EphA2 overexpression promoted migration
in a ligand-independent manner [11]. On the basis of this
evidence, our observation of high expression of EphA2
without ephrinA1 is a reasonable finding for explanation
of high invasive and metastatic potential of ACC. Presum-
ably EphA2 might play a role in ACC metastasis inde-
pendent of the presence of ephrin-A1. Anyway it was
worth to further investigate the function of EphA2 in
ACC cell migration and invasion.
We provide the evidence that expression of EphA2
and induction of EMT have occurred in a case of ACC
metastasis and discuss the possibility that EphA2 and
EMT are involved as a mechanism of ACC metastasis.
However, it remains unclear whether the EphA2 signal-
ing could induce EMT program. A number of EMT in-
ducers have been identified that include growth factors,
cytokines and microRNAs, and diverse signaling path-
ways have been reported to regulate EMT [7]. In the lit-
erature, EphA2 signaling in epithelial and cancer cells
can induce morphological changes reminiscent of tran-
sition between epithelial and mesenchymal states [5].
Concretely, stimulation of EphA2 forward signaling
with ephrin-A1 enhances the maturation of cell–cell
junctions and cell compaction, leading to an epithelial
phenotype [5]. Moreover, E-cadherin can promote EphA2
expression and surface localization in epithelial and cancer
cells, thereby prolonging EphA2 interaction with ephrin-
Fukai et al. BMC Research Notes 2014, 7:131 Page 6 of 6
http://www.biomedcentral.com/1756-0500/7/131A1 [5]. Therefore, it may be possible that, without
ephrin-A1 stimulation, EphA2 overexpression and for-
ward signaling down-regulate E-cadherin in a feedback
loop, inducing a phenotypic change from epithelial to
mesenchymal character; however, it remains to be elu-
cidated and further investigation should be needed.
Conclusions
Finally, the results of our study revealed that EMT might
be involved in the ACC metastatic process. We also
showed that the expression of EphA2, without ephrinA1,
is elevated in our case of ACC with intracranial exten-
sion. Although in vitro and in vivo experiments should
be necessary to elucidate whether aberrant EphA2 sig-
naling could induce EMT program, resulting in invasion
and metastasis of ACC, targeting these processes might
be an attractive but challenging approach that is likely to
lead to improved clinical management of ACC patients.
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